POSITIVELY AWARE MARCH/APRIL 2011
| Drug Class | |
| Drug | Page |
| NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (also called nucleoside analogs, NRTIs, or nukes) |
|
| Combivir (Epivir/Retrovir) |
21 |
| Emtriva (emtricitabine, or FTC) |
22 |
| Epivir (lamivudine, or 3TC) |
23 |
| Epzicom (Epivir/Ziagen) |
24 |
| Retrovir (zidovudine, or AZT) |
25 |
| Trizivir (Epivir/Retrovir/Ziagen) |
26 |
| Truvada (Emtriva/Viread) |
27 |
| Videx EC (didanosine, or ddI) |
28 |
| Viread (tenofovir) |
29 |
| Zerit (stavudine, or d4T) |
30 |
| Ziagen (abacavir) | 31 |
| NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (also called non-nucleoside analogs, NNRTIs, or non-nukes) |
|
| Intelence (etravirine, or TMC-125) |
32 |
| Rescriptor (delavirdine) |
33 |
| rilpivirine | 34 |
| Sustiva (efavirenz) |
35 |
| Viramune (nevirapine) | 36 |
| FIXED DOSE REGIMENS | |
| Atripla (Sustiva/Truvada [Emtriva plus Viread]) | 37 |
| rilpivirine/Truvada combination | 38 |
| PROTEASE INHIBITORS (PIs) | |
| Aptivus (tipranavir) |
39 |
| Crixivan (indinavir) |
40 |
| Invirase (saquinavir) |
41 |
| Kaletra (lopinavir/ritonavir) |
42 |
| Lexiva (fos-amprenavir) |
43 |
| Norvir (ritonavir) |
44 |
| Prezista (darunavir) |
45 |
| Reyataz (atazanavir) |
46 |
| Viracept (nelfinavir) | 47 |
| ENTRY INHIBITORS | |
| Fuzeon (enfuvirtide, or T-20) |
48 |
| Selzentry (maraviroc) | 49 |
| INTEGRASE INHIBITORS | |
| Isentress (raltegravir) | 50 |
